意大利儿童患有腹腔疾病的SARS-CoV-2疫苗接种覆盖率
Carlotta Pepino1, Federica Malerba1,2, Valentina Biagioli1
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Child and Maternal Health, University of Genova, 16100 Genova, Italy.
Journal of clinical medicine
|October 16, 2024
概括
儿科乳病 (CD) 患者的SARS-CoV-2疫苗接种覆盖率较低,特别是在年幼的儿童中. 疫苗的犹仍然存在,这凸显了在这个弱势群体中更好地遵守疫苗接种建议的必要性.
科学领域:
- 儿科自身免疫性疾病儿童自身免疫性疾病
- 传染病流行病学 传染病流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 乳病 (CD) 是儿童常见的一种自身免疫性疾病.
- 关于儿童CD患者的SARS-CoV-2疫苗接种率的数据有限.
- 了解接种疫苗的坚持对于公共卫生战略至关重要.
研究的目的:
- 评估患有CD的儿童和青少年的SARS-CoV-2疫苗接种覆盖率.
- 分析随着时间的推移对接种疫苗的坚持趋势.
- 为了确定影响这一群体接种疫苗的因素.
主要方法:
- 医疗记录和疫苗注册册册的回顾性分析.
- 包括诊断为CD的0-19岁的患者.
- 根据年龄组和资格期的疫苗接种范围的评估.
主要成果:
- 44.8%的儿科CD患者至少接种了一剂SARS-CoV-2疫苗.
- 在最初的高峰之后,覆盖率下降,与资格扩大和感染率下降相关.
- 组织学诊断和其他自身免疫性疾病的患者观察到更高的坚持.
结论:
- 意大利的CD患儿的SARS-CoV-2疫苗接种程度较低,但在青少年中更好.
- 疫苗犹是一个重大问题,特别是在生物检查节省CD诊断.
- 需要有针对性的干预措施来提高儿科CD患者的疫苗接种率.
相关概念视频
Vaccinations
Overview
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


